BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 26138283)

  • 21. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Alyami M; Mercier F; Siebert M; Bonnot PE; Laplace N; Villeneuve L; Passot G; Glehen O; Bakrin N; Kepenekian V
    Eur J Surg Oncol; 2021 Jan; 47(1):128-133. PubMed ID: 31253545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Graversen M; Detlefsen S; Bjerregaard JK; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2017 Jun; 34(5):309-314. PubMed ID: 28516306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers.
    Dumont F; Passot C; Raoul JL; Kepenekian V; Lelièvre B; Boisdron-Celle M; Hiret S; Senellart H; Pein F; Blanc-Lapierre A; Raimbourg J; Thibaudeau E; Glehen O;
    Eur J Cancer; 2020 Nov; 140():37-44. PubMed ID: 33039812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review.
    Ploug M; Graversen M; Pfeiffer P; Mortensen MB
    BMC Cancer; 2020 Feb; 20(1):105. PubMed ID: 32041558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pressurized Intraperitoneal Aerosol Chemotherapy-Related Clinical Trials in the Treatment of Peritoneal Metastases.
    Ukegjini K; Putora PM; Guidi M; Süveg K; Cihoric N; Widmann B; Steffen T
    Oncology; 2021; 99(9):601-610. PubMed ID: 34265774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study.
    Lee EJ; Park SJ; Lee J; Mun J; Paik H; Seol A; Kim J; Yim GW; Shim SH; Kim HS; Chang SJ;
    Anticancer Res; 2022 Jan; 42(1):363-371. PubMed ID: 34969746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pressurized intraperitoneal aerosol chemotherapy (PIPAC): a new way of administration in peritoneal carcinomatosis of ovarian cancer].
    Sabaila A; Fauconnier A; Huchon C
    Gynecol Obstet Fertil; 2015 Jan; 43(1):66-7. PubMed ID: 25523545
    [No Abstract]   [Full Text] [Related]  

  • 29. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: systematic review of clinical and experimental evidence with special emphasis on ovarian cancer.
    Tempfer C; Giger-Pabst U; Hilal Z; Dogan A; Rezniczek GA
    Arch Gynecol Obstet; 2018 Aug; 298(2):243-257. PubMed ID: 29869089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases.
    Kim G; Tan HL; Sundar R; Lieske B; Chee CE; Ho J; Shabbir A; Babak MV; Ang WH; Goh BC; Yong WP; Wang L; So JBY
    Clin Cancer Res; 2021 Apr; 27(7):1875-1881. PubMed ID: 33148667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report.
    Siebert M; Alyami M; Mercier F; Gallice C; Villeneuve L; Bérard F; Glehen O; Bakrin N; Kepenekian V
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):425-430. PubMed ID: 30511218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience.
    Tempfer CB; Celik I; Solass W; Buerkle B; Pabst UG; Zieren J; Strumberg D; Reymond MA
    Gynecol Oncol; 2014 Feb; 132(2):307-11. PubMed ID: 24275155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
    Alyami M; Bonnot PE; Mercier F; Laplace N; Villeneuve L; Passot G; Bakrin N; Kepenekian V; Glehen O
    Eur J Surg Oncol; 2021 Jan; 47(1):123-127. PubMed ID: 32561204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases in Solid Organ Graft Recipients: First Experience.
    Horvath P; Yurttas C; Struller F; Bösmüller H; Lauer UM; Nadalin S; Königsrainer A; Reymond MA
    Ann Transplant; 2019 Jan; 24():30-35. PubMed ID: 30643112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis.
    Tempfer CB; Giger-Pabst U; Seebacher V; Petersen M; Dogan A; Rezniczek GA
    Gynecol Oncol; 2018 Jul; 150(1):23-30. PubMed ID: 29743140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncological Outcomes After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Peritoneal Carcinomatosis.
    Tidadini F; Abba J; Quesada JL; Trilling B; Bonne A; Foote A; Faucheron JL; Arvieux C
    J Gastrointest Cancer; 2023 Jun; 54(2):632-641. PubMed ID: 35778645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient.
    Graversen M; Detlefsen S; Ellebaek SB; Fristrup C; Pfeiffer P; Mortensen MB
    Eur J Surg Oncol; 2020 Jan; 46(1):155-159. PubMed ID: 31493986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
    Graversen M; Detlefsen S; Ainsworth AP; Fristrup CW; Knudsen AO; Pfeiffer P; Tarpgaard LS; Mortensen MB
    Ann Surg Oncol; 2023 May; 30(5):2634-2644. PubMed ID: 36602663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowel cancer.
    Gockel I; Jansen-Winkeln B; Haase L; Niebisch S; Moulla Y; Lyros O; Lordick F; Schierle K; Wittekind C; Thieme R
    Tumori; 2020 Feb; 106(1):70-78. PubMed ID: 31469058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer.
    Rezniczek GA; Giger-Pabst U; Thaher O; Tempfer CB
    BMC Cancer; 2020 Nov; 20(1):1122. PubMed ID: 33213407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.